Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine.

Maron BJ, Ommen SR, Semsarian C, Spirito P, Olivotto I, Maron MS.

J Am Coll Cardiol. 2014 Jul 8;64(1):83-99. doi: 10.1016/j.jacc.2014.05.003. Review. Erratum in: J Am Coll Cardiol. 2014 Sep 16;64(11):1188.

2.

[Hypertrophic cardiomyopathy: current aspects and new developments].

Desnos M.

Bull Acad Natl Med. 2012 Apr-May;196(4-5):997-1009; discussion 1009-10. French.

PMID:
23550458
3.

Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.

Maron BJ, Rowin EJ, Casey SA, Link MS, Lesser JR, Chan RH, Garberich RF, Udelson JE, Maron MS.

J Am Coll Cardiol. 2015 May 12;65(18):1915-28. doi: 10.1016/j.jacc.2015.02.061.

4.

Hypertrophic cardiomyopathy.

Maron BJ, Maron MS.

Lancet. 2013 Jan 19;381(9862):242-55. doi: 10.1016/S0140-6736(12)60397-3. Epub 2012 Aug 6. Review.

PMID:
22874472
5.

Hypertrophic cardiomyopathy: a systematic review.

Maron BJ.

JAMA. 2002 Mar 13;287(10):1308-20. Review.

PMID:
11886323
6.

Hypertrophic Cardiomyopathy in Children, Adolescents, and Young Adults Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.

Maron BJ, Rowin EJ, Casey SA, Lesser JR, Garberich RF, McGriff DM, Maron MS.

Circulation. 2016 Jan 5;133(1):62-73. doi: 10.1161/CIRCULATIONAHA.115.017633. Epub 2015 Oct 30.

7.

Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.

Maron MS, Finley JJ, Bos JM, Hauser TH, Manning WJ, Haas TS, Lesser JR, Udelson JE, Ackerman MJ, Maron BJ.

Circulation. 2008 Oct 7;118(15):1541-9. doi: 10.1161/CIRCULATIONAHA.108.781401. Epub 2008 Sep 22.

8.

The 20 advances that have defined contemporary hypertrophic cardiomyopathy.

Maron BJ, Maron MS.

Trends Cardiovasc Med. 2015 Jan;25(1):54-64. doi: 10.1016/j.tcm.2014.09.004. Review.

PMID:
25446045
10.

Management of hypertrophic cardiomyopathy.

Enriquez AD, Goldman ME.

Ann Glob Health. 2014 Jan-Feb;80(1):35-45. doi: 10.1016/j.aogh.2013.12.004. Epub 2013 Dec 25. Review.

11.

Hypertrophic cardiomyopathy: a review of etiology and treatment.

Jurynec J.

J Cardiovasc Nurs. 2007 Jan-Feb;22(1):65-73; quiz 74-5. Review.

PMID:
17224700
12.

New trends in treatment of hypertrophic cardiomyopathy.

Hagège AA, Desnos M.

Arch Cardiovasc Dis. 2009 May;102(5):441-7. doi: 10.1016/j.acvd.2009.03.008. Epub 2009 May 12. Review.

13.

[Interventional treatment in hypertrophic cardiomyopathy].

Gietzen FH, Schümmelfeder J, Neuser H, Brunn J, Schumacher B, Kerber S.

Herz. 2005 Mar;30(2):102-10. Review. German.

PMID:
15875098
14.

Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.

Maron BJ, Spirito P, Ackerman MJ, Casey SA, Semsarian C, Estes NA 3rd, Shannon KM, Ashley EA, Day SM, Pacileo G, Formisano F, Devoto E, Anastasakis A, Bos JM, Woo A, Autore C, Pass RH, Boriani G, Garberich RF, Almquist AK, Russell MW, Boni L, Berger S, Maron MS, Link MS.

J Am Coll Cardiol. 2013 Apr 9;61(14):1527-35. doi: 10.1016/j.jacc.2013.01.037.

15.

Contemporary strategies for risk stratification and prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy.

Maron BJ, Maron MS.

Heart Rhythm. 2016 May;13(5):1155-65. doi: 10.1016/j.hrthm.2015.12.048. Epub 2016 Jan 1. Review.

PMID:
26749314
16.

[Prevention of sudden death in hypertrophic cardiomyopathy (HCM ): implanted defibrillators in HCM].

Maron BJ, Spirito P.

Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Apr;37(4):297-302. Chinese.

PMID:
19791462
17.

Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy.

Maron BJ, Spirito P.

J Cardiovasc Electrophysiol. 2008 Oct;19(10):1118-26. doi: 10.1111/j.1540-8167.2008.01147.x. Epub 2008 Mar 31. Review.

PMID:
18384577
18.

Controversies in cardiovascular medicine. Benefits of surgery in obstructive hypertrophic cardiomyopathy: bring septal myectomy back for European patients.

Maron BJ, Yacoub M, Dearani JA.

Eur Heart J. 2011 May;32(9):1055-8. doi: 10.1093/eurheartj/ehr006. Epub 2011 Feb 14. Review.

PMID:
21324934
19.

Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

Maron MS.

J Cardiovasc Magn Reson. 2012 Feb 1;14:13. doi: 10.1186/1532-429X-14-13. Review.

20.

Clinical characteristics and outcomes of dilated phase of hypertrophic cardiomyopathy: report from the registry data in Japan.

Goto D, Kinugawa S, Hamaguchi S, Sakakibara M, Tsuchihashi-Makaya M, Yokota T, Yamada S, Yokoshiki H, Tsutsui H; JCARE-CARD Investigators.

J Cardiol. 2013 Jan;61(1):65-70. doi: 10.1016/j.jjcc.2012.08.010. Epub 2012 Oct 15.

Supplemental Content

Support Center